Download PDF

Other users also viewed these articles

Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma Shuangmei Zhu; Yong Chen; Hong Ye; Baoqiang Wang; Xiang Lan; Hanying Wang; Sijie Ding; Xiao He;
10.1016/j.aohep.2022.100678
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab Lorenz Kocheise; Jan Kempski; Yunhe Tang; Lorenz Balcar; Victoria Berger; Miriam Tomczak; Joao Gorgulho; Ramsha Masood; Franziska Giehren; Constantin Schmidt; Jan P. Sutter; Thorben W. Fruendt; Francesca Pagani; Sophie Wulf; Julian Kött; Saskia Domanig; Anastasios Giannou; Tanja Bedke; Jöran Lücke; Tao Zhang; Siwen Zhang; Andres Machicote; Ansgar W. Lohse; Marianna Alunni-Fabbroni; Jens Ricke; Najib Ben Khaled; Matthias Pinter; Bernhard Scheiner; Samuel Huber; Johann von Felden; Ignazio Piseddu; Kornelius Schulze;
10.1016/j.aohep.2025.102138
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma Stephen Lam Chan; Richard S. Finn; Julien Edeline; Sadahisa Ogasawara; Jennifer J. Knox; Bruno Daniele; Baek-Yeol Ryoo; Philippe Merle; Mohamed Bouattour; Ho-Yeong Lim; Yee Chao; Thomas Yau; Barbara Anne Haber; Usha Malhotra; Abby B. Siegel; Chih-Chin Liu; Masatoshi Kudo; Ann-Lii Cheng;
10.1016/j.aohep.2025.102169